Sarcomeric hypertrophic cardiomyopathy is the most common cardiovascular genetic disease. Clinical evaluation and comprehensive echocardiography are crucial for the diagnosis and early evaluation of the hypertrophic phenotype, but multimodality imaging approach is often required to better define diagnosis and differential diagnosis from phenocopies. This review aims to assess the role of multimodality imaging and, in particular, advanced echocardiography and cardiac magnetic resonance in relation to differential diagnosis and preclinical diagnosis, identification of different phenotypes, and assessment of disease progression and risk of sudden cardiac death. A multimodality imaging approach is also crucial for the selection of patients amenable to surgical or percutaneous septal myectomy and for guiding both procedures.

Guido, V., Campana, M., Pino, P., Moreo, A., De Chiara, B., Bertella, E., et al. (2019). Valutazione clinica della cardiomiopatia ipertrofica: ruolo dell’imaging multimodale [Clinical evaluation of hypertrophic cardiomyopathy: role of multimodal imaging]. GIORNALE ITALIANO DI CARDIOLOGIA, 20(12), 746-761 [10.1714/3271.32383].

Valutazione clinica della cardiomiopatia ipertrofica: ruolo dell’imaging multimodale [Clinical evaluation of hypertrophic cardiomyopathy: role of multimodal imaging]

Moreo A.;De Chiara B.;
2019

Abstract

Sarcomeric hypertrophic cardiomyopathy is the most common cardiovascular genetic disease. Clinical evaluation and comprehensive echocardiography are crucial for the diagnosis and early evaluation of the hypertrophic phenotype, but multimodality imaging approach is often required to better define diagnosis and differential diagnosis from phenocopies. This review aims to assess the role of multimodality imaging and, in particular, advanced echocardiography and cardiac magnetic resonance in relation to differential diagnosis and preclinical diagnosis, identification of different phenotypes, and assessment of disease progression and risk of sudden cardiac death. A multimodality imaging approach is also crucial for the selection of patients amenable to surgical or percutaneous septal myectomy and for guiding both procedures.
Articolo in rivista - Articolo scientifico
Role of multimodality imaging in the clinical evaluation of hypertrophic cardiomyopathy
Italian
2019
20
12
746
761
none
Guido, V., Campana, M., Pino, P., Moreo, A., De Chiara, B., Bertella, E., et al. (2019). Valutazione clinica della cardiomiopatia ipertrofica: ruolo dell’imaging multimodale [Clinical evaluation of hypertrophic cardiomyopathy: role of multimodal imaging]. GIORNALE ITALIANO DI CARDIOLOGIA, 20(12), 746-761 [10.1714/3271.32383].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/265269
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact